LONDON: AstraZeneca and Oxford University's COVID-19 vaccine has similar efficacy against the British coronavirus variant as it does to the previously circulating variants, the university said on Friday.
The variant, first identified in Kent, southern England, is more easily transmissible, prompting many countries to restrict travel to Britain. It also led to a spike in infections that forced a new national lockdown in England last month.
That lockdown came as Britain started rolling out the AstraZeneca vaccine. Over 10 million people have received a first dose of either AstraZeneca or Pfizer's shot.
Britain had said that it believed the vaccines were effective against variants that are circulating in the UK.
"Data from our trials of the ChAdOx1 vaccine in the United Kingdom indicate that the vaccine not only protects against the original pandemic virus, but also protects against the novel variant, B.1.1.7, which caused the surge in disease from the end of 2020 across the UK," said Andrew Pollard, Chief Investigator on the Oxford vaccine trial.
Sarah Gilbert, co-developer of the vaccine, said that, although the vaccine had efficacy against the UK variant, it might need to be adapted for a future variant.
"We are working with AstraZeneca to optimise the pipeline required for a strain change should one become necessary," Gilbert said.
The findings, released in a preprint paper and not peer-reviewed, also detailed recent analysis showing that vaccination with the shot results in a reduction in the duration of shedding and viral load, which may translate into a reduced transmission of the disease, Oxford University said.
Oxford says COVID-19 vaccine with AstraZeneca works against UK variant
https://arab.news/ny758
Oxford says COVID-19 vaccine with AstraZeneca works against UK variant
- The variant is more easily transmissible, prompting many countries to restrict travel to Britain
- It also led to a spike in infections that forced a new national lockdown in England last month
Israeli firm loses British Army contract bid
- Subsidiary Elbit Systems UK’s campaign for $2.6bn program was marred by controversy
- Senior govt civil servant overseeing contract was dined, handed free Israel tour
LONDON: A UK subsidiary of Israeli weapons giant Elbit Systems has lost its bid to win a prominent British Army contract, The Times reported.
The loss followed high-profile reporting on controversy surrounding Elbit Systems UK’s handling of the bid.
The subsidiary led one of two major arms consortiums attempting to secure the $2.6 billion bid to prepare British soldiers for war and overhaul army standards.
Rivaling Elbit, the other consortium led by Raytheon UK, a British subsidiary of the US defense giant, ultimately won the contract, a Ministry of Defence insider told The Times.
It had been decided following an intricate process that Raytheon was a “better candidate,” the source said.
Elbit Systems UK’s controversial handling of its contract campaign was revealed in reports by The Times.
A whistleblower had compiled a dossier surrounding the bid that was shown to the MoD last August, though the report was privately revealed to the ministry months earlier.
It alleged that Elbit UK had breached business appointment rules when Philip Kimber, a former British Army brigadier, had reportedly shared information with the firm after leaving the military.
Kimber attending critical meetings at the firm to discuss the training contract that he had once overseen at the ministry, the report alleged.
In one case, Kimber was present in an Elbit meeting and sitting out of view of a camera. He reportedly said he “should not be there,” according to the whistleblower’s report.
In response to a freedom of information request, the MoD later admitted that it had held the dossier for seven months without investigating its claims. Insiders at the ministry blamed the investigative delay on “administrative oversight.”
A month after being pushed on the allegations by The Times, a senior civil servant completed an “assurance review” in September and found that business appointment rules had not been breached.
Other allegations concerned lunches and dinners hosted by Elbit UK in which civil servants at the heart of the contract decision process were invited.
One senior civil servant was dined by the British subsidiary seven times, while rival Raytheon did not host events.
Mike Cooper, the senior responsible owner at army headquarters for the army training program, also traveled to Jerusalem with two senior British military officers.
He took part in a sightseeing tour funded by Elbit Systems, the British subsidiary’s parent company.
In response to the allegations, an MoD spokesperson said in a statement: “The collective training transformation programme will modernise training for soldiers to ensure the British Army can face down the threats of the future.
“We will not comment further until a preferred tenderer announcement is made public in due course.”
Amid mounting criticism of Israel within the British military establishment, four former senior army officers, in a letter to Prime Minister Keir Starmer, recently urged the government to end involvement with Israeli-owned or Israeli-supported weapons companies.
“Now is not the time to return to business as usual with the Israeli government,” they wrote, urging harsher sanctions.
